Dcm Advisors, LLC Eli Lilly & CO Transaction History

Dcm Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $266,796 - $314,518	508 New	508 $296,000
Q4 2022 Sep 08, 2023	SELL	$321.55 - $374.67 $1.48 Million - $1.73 Million	-4,612 Closed	0 $0
Q3 2022 Sep 08, 2023	SELL	$296.48 - $337.87 $117,109 - $133,458	-395 Reduced 7.89%	4,612 $1.49 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $583,939 - $685,630	-2,095 Reduced 29.5%	5,007 $1.62 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $58,672 - $72,915	-250 Reduced 3.4%	7,102 $2.03 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $476,457 - $591,285	2,119 Added 40.49%	7,352 $2.03 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.16 Million - $1.43 Million	5,233 New	5,233 $1.21 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcm Advisors, LLC with notifications on news.